Arrowhead Pharmaceuticals, Inc.
ARWR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000879407
In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Arrowhead Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 314
- +26 vs. Q1 2021
- Shares held
- 67.0M
- −1.62M (−2.4%) vs. Q1 2021
- Total value
- $5.54B
- +$995.1M (+21.9%) vs. Q1 2021
- New holders
- 53
- 98 more added
- Sold out
- 27
- 108 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARWR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 501 | $9.73B |
| Q1 2026 | 437 | $7.58B |
| Q4 2025 | 401 | $7.70B |
| Q3 2025 | 303 | $3.83B |
| Q2 2025 | 281 | $1.67B |
| Q1 2025 | 264 | $1.34B |
| Q4 2024 | 269 | $1.88B |
| Q3 2024 | 272 | $1.90B |
| Q2 2024 | 272 | $2.54B |
| Q1 2024 | 273 | $2.76B |
| Q4 2023 | 266 | $2.37B |
| Q3 2023 | 257 | $2.01B |
| Q2 2023 | 274 | $2.57B |
| Q1 2023 | 257 | $1.85B |
| Q4 2022 | 282 | $2.97B |
| Q3 2022 | 278 | $2.35B |
| Q2 2022 | 279 | $2.54B |
| Q1 2022 | 307 | $3.19B |
| Q4 2021 | 311 | $4.51B |
| Q3 2021 | 297 | $4.16B |
| Q2 2021 | 314 | $5.54B |
| Q1 2021 | 289 | $4.55B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Arrowhead Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 1,116,880 | $92.5M | 0.04% | +50,883+4.8% | Added |
| First Manhattan Co | 1,133,563 | $93.9M | 0.34% | +3170.0% | Added |
| Janus Henderson Group PLC | 1,141,595 | $94.5M | 0.04% | +1,282+0.1% | Added |
| Fiera Capital Corp | 1,214,964 | $100.6M | 0.26% | −32,850−2.6% | Reduced |
| FMR LLC | 1,283,929 | $106.3M | 0.01% | −28,122−2.1% | Reduced |
| Credit Suisse AG | 1,392,194 | $115.3M | 0.09% | −97,522−6.5% | Reduced |
| Northern Trust Corp | 1,491,038 | $123.5M | 0.02% | −55,030−3.6% | Reduced |
| Geode Capital Management, LLC | 1,808,802 | $149.8M | 0.02% | +52,292+3.0% | Added |
| Invesco Ltd. | 2,506,516 | $207.6M | 0.05% | −884,393−26.1% | Reduced |
| JPMorgan Chase & Co | 2,646,045 | $219.1M | 0.03% | +73,123+2.8% | Added |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $270.1M | 27.61% | 00.0% | Unchanged |
| State Street Corp | 3,586,331 | $297.0M | 0.02% | −147,789−4.0% | Reduced |
| Vanguard Group Inc | 9,639,064 | $798.3M | 0.02% | +37,927+0.4% | Added |
| BlackRock Inc. | 12,149,503 | $1.01B | 0.03% | −751,724−5.8% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −182,704−100.0% | Sold out |
| Nikko Asset Management Americas, Inc. | 0 | $0 | 0.00% | −182,704−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −70,089−100.0% | Sold out |
| Uniplan Investment Counsel, Inc. | 0 | $0 | 0.00% | −40,469−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −34,758−100.0% | Sold out |
| Mackay Shields LLC | 0 | $0 | 0.00% | −32,600−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −32,500−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −27,249−100.0% | Sold out |
| Advisors Preferred, LLC | 0 | $0 | 0.00% | −19,194−100.0% | Sold out |
| South Dakota Investment Council | 0 | $0 | 0.00% | −15,334−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −11,145−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −10,599−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −10,159−100.0% | Sold out |
| Foundry Partners, LLC | 0 | $0 | 0.00% | −9,551−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −6,316−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −6,013−100.0% | Sold out |
| LS Investment Advisors, LLC | 0 | $0 | 0.00% | −5,408−100.0% | Sold out |
| Defender Capital, LLC. | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −3,980−100.0% | Sold out |
| Illinois Municipal Retirement Fund | 0 | $0 | 0.00% | −2,908−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −2,424−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −1,631−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −1,123−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −683−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −213−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Amundi Asset Management US, Inc. | – | – | – | – | Not filed |